The KN510713 Study in Combination With mFOLFIRINOX

Clinical trial NCT07114861 · RECRUITING

Trial details

NCT number: NCT07114861
Sponsor: New Cancer Cure-Bio Co.,Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Start date: 2025-12-16
Primary completion: 2028-09-22
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.